Jagsonpal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
212.29
2.2 (1.05%)
BSENSE

May 12

BSE+NSE Vol: 1.66 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024

Compare Balance Sheet Results of Jagsonpal Pharma
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
43.79
-30.51
-69.67%
Share Warrants & Outstandings
Total Reserve
204.71
19.05
185.66
974.59%
Shareholder's Funds
239.95
62.84
177.11
281.84%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
3.11
-3.11
-100.00%
Secured Loans
0.00
1.64
-1.64
-100.00%
Unsecured Loans
0.00
1.48
-1.48
-100.00%
Deferred Tax Assets / Liabilities
3.07
3.41
-0.34
-9.97%
Other Long Term Liabilities
8.30
0.13
8.17
6,284.62%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
0.00
1.04
0.00%
Total Non-Current Liabilities
12.41
6.65
5.76
86.62%
Current Liabilities
Trade Payables
9.73
9.22
0.51
5.53%
Other Current Liabilities
15.16
4.27
10.89
255.04%
Short Term Borrowings
0.00
1.06
-1.06
-100.00%
Short Term Provisions
1.01
2.74
-1.73
-63.14%
Total Current Liabilities
25.90
17.28
8.62
49.88%
Total Liabilities
278.26
86.77
191.49
220.69%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
43.42
50.05
115.27%
Less: Accumulated Depreciation
7.25
24.03
-16.78
-69.83%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
19.40
66.83
344.48%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.95
-1.95
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
1.33
0.00
1.33
0.00%
Other Non Current Assets
21.29
0.00
21.29
0.00%
Total Non-Current Assets
117.07
21.34
95.73
448.59%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
9.95
5.25
52.76%
Sundry Debtors
13.18
8.77
4.41
50.29%
Cash and Bank
128.73
12.12
116.61
962.13%
Other Current Assets
1.66
20.17
-18.51
-91.77%
Short Term Loans and Advances
2.42
14.42
-12.00
-83.22%
Total Current Assets
161.19
65.43
95.76
146.35%
Net Current Assets (Including Current Investments)
135.29
48.14
87.15
181.03%
Total Current Assets Excluding Current Investments
161.19
65.43
95.76
146.35%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
86.77
191.49
220.69%
Contingent Liabilities
16.17
1.40
14.77
1,055.00%
Total Debt
0.00
4.18
-4.18
-100.00%
Book Value per share (adjusted)
36.08
1.44
34.64
2,405.56%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024